Literature DB >> 1600047

Review article: the treatment of Helicobacter pylori infection.

R V Heatley1.   

Abstract

The discovery of Helicobacter pylori has stimulated great interest in its role in gastritis, non-ulcer dyspepsia and peptic ulceration. Treatment regimens to eradicate this organism from gastric mucosa have also received considerable attention. Current recommendations limit the use of triple drug combinations only to specific patient groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600047     DOI: 10.1111/j.1365-2036.1992.tb00051.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Over the counter H2 receptor antagonists. Serve only as expensive antacids.

Authors:  A C Douds; J D Maxwell
Journal:  BMJ       Date:  1994-10-29

2.  Helicobacter pylori positive resistant duodenal ulcers.

Authors:  M Guslandi
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

3.  A pilot study of a randomized controlled trial of pragmatic eradication of Helicobactor pylori in primary care.

Authors:  J Hippisley-Cox; M Pringle
Journal:  Br J Gen Pract       Date:  1997-06       Impact factor: 5.386

4.  Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats.

Authors:  H Endo; H Yoshida; N Ohmi; S Higuchi
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 5.  Diagnostic methods for Helicobacter pylori detection and eradication.

Authors:  A F Goddard; R P H Logan
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

6.  Long term acid suppressing treatment in general practice.

Authors:  S D Ryder; S O'Reilly; R J Miller; J Ross; M R Jacyna; A J Levi
Journal:  BMJ       Date:  1994-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.